| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.18 | 6e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |